171 related articles for article (PubMed ID: 3119655)
1. Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.
Lanzone A; Fulghesu AM; Spina MA; Apa R; Menini E; Caruso A; Mancuso S
J Clin Endocrinol Metab; 1987 Dec; 65(6):1253-8. PubMed ID: 3119655
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist administration in polycystic ovary syndrome.
Buckler HM; Phillips SE; Kovacs GT; Burger HG; Healy DL
Clin Endocrinol (Oxf); 1989 Aug; 31(2):151-65. PubMed ID: 2514053
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
4. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
[TBL] [Abstract][Full Text] [Related]
5. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
Buckler HM; Critchley HO; Cantrill JA; Shalet SM; Anderson DC; Robertson WR
Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles.
Lanzone A; Fulghesu AM; Villa P; Guida C; Guido M; Nicoletti MC; Caruso A; Mancuso S
Fertil Steril; 1994 Jul; 62(1):35-41. PubMed ID: 8005301
[TBL] [Abstract][Full Text] [Related]
8. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
[TBL] [Abstract][Full Text] [Related]
9. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
10. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome.
Noci I; Maggi M; Fuzzi B; Biagiotti R; Ricci F; Marchionni M
Gynecol Endocrinol; 2000 Oct; 14(5):321-6. PubMed ID: 11109971
[TBL] [Abstract][Full Text] [Related]
11. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
12. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
Schachter M; Balen AH; Patel A; Jacobs HS
Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
[TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian disease.
Lanzone A; Fulghesu AM; Conte M; Apa R; Caruso A; Mancuso S
Fertil Steril; 1987 Dec; 48(6):1058-61. PubMed ID: 3119371
[TBL] [Abstract][Full Text] [Related]
14. Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.
Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
Int J Gynaecol Obstet; 1989 Feb; 28(2):163-9. PubMed ID: 2563704
[TBL] [Abstract][Full Text] [Related]
15. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
Kuroda G
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
17. Acute ovarian responses to a long-acting agonist of gonadotropin-releasing hormone in ovulatory women and women with polycystic ovarian disease.
DeFazio J; Meldrum DR; Lu JK; Vale WW; Rivier JE; Judd HL; Chang RJ
Fertil Steril; 1985 Oct; 44(4):453-9. PubMed ID: 3932097
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
19. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
[TBL] [Abstract][Full Text] [Related]
20. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
